Association between serum interleukin-6 concentration and mortality in patients with coronary artery disease

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Su, Dongfang ^a   Li, Zhongxia ^a   Li, Xinrui ^a   Chen, Yuming ^a   Zhang, Yuan ^b   Ding, Ding ^a,c   Deng, Xueqing ^a   Xia, Min ^a   Qiu, Jian ^b   Ling, Wenhua ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR RISK; FEMALE; FOLLOW UP; HOSPITAL PATIENT; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; ANIMAL; BLOOD; CORONARY ARTERY DISEASE; REVIEW; RISK FACTOR;

ANIMALS; CORONARY ARTERY DISEASE; HUMANS; INTERLEUKIN-6; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84879321542     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/726178     Document Type: Article

References (35)

1. Luc G., Bard J. M., Juhan-Vague I., Ferrieres J., Evans A., Amouyel P., Arveiler D., Fruchart J. C., Ducimetiere P., C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME study. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 7 1255 1261 2-s2.0-0038108728 10.1161/01.ATV.0000079512.66448.1D
2. Shlipak M. G., Ix J. H., Bibbins-Domingo K., Lin F., Whooley M. A., Biomarkers to predict recurrent cardiovascular disease: the heart and soul study. American Journal of Medicine 2008 121 1 50 57 2-s2.0-37749041680 10.1016/j.amjmed.2007.06.030
3. Lee J. K., Bettencourt R., Brenner D., Le T. A., Barrett-Connor E., Loomba R., Association between serum interleukin-6 concentrations and mortality in older adults: the rancho bernardo study. PLoS ONE 2012 7 e34218
4. Pudil R., Tichy M., Blaha V., Andrys C., Vojacek J., Plasma interleukin 6 level is associated with nt-probnp level and predicts short- and long-term mortality in patients with acute heart failure. European Heart Journal Supplements 2010 12 F91
5. Scharnagl H., Stojakovic T., Weihrauch G., Winkelmann B. R., Boehm B. O., Maerz W., Interleukin-6 is stronger associated with all-cause and cardiovascular mortality than c-reactive protein, serum amyloid a and fibrinogen (the luric study). Atherosclerosis Supplements 2010 11 42 42
6. Fan Z. X., Hua Q., Tan J., Gao J., Liu R. K., Yang Z., Interleukin-6 but not soluble adhesion molecules has short-term prognostic value on mortality in patients with acute ST-segment elevation myocardial infarction. African Journal of Biotechnology 2011 10 8 1454 1459 2-s2.0-79952147394
7. Zakynthinos E., Pappa N., Inflammatory biomarkers in coronary artery disease. Journal of Cardiology 2009 53 3 317 333 2-s2.0-65849453194 10.1016/j.jjcc.2008.12.007
8. Fan Z. X., Hua Q., Li Y. P., Liu R. K., Yang Z., Interleukin-6, but not soluble adhesion molecules, predicts a subsequent mortality from cardiovascular disease in patients with acute st-segment elevation myocardial infarction. Cell Biochemistry and Biophysics 2011 61 443 448
9. James S., Siegbahn A., Wallentin L., Interleukin-6 is a better predictor of mortality than c-reactive protein very early after symptom onset in patients with non-st elevation acute coronary syndrome. Journal of the American College of Cardiology 2004 43 1A
10. Papanicolaou D. A., Wilder R. L., Manolagas S. C., Chrousos G. P., The pathophysiologic roles of interleukin-6 in human disease. Annals of Internal Medicine 1998 128 2 127 137 2-s2.0-0031963046
11. Lv X., Zhang Y., Rao S., Joint effects of genetic variants in multiple loci on the risk of coronary artery disease in chinese han subjects. Circulation Journal 2012 76 1987 1992
12. Lv X. F., Zhang Y., Rao S. Q., Lack of association between four snps in the slc22a3-lpal2-lpa gene cluster and coronary artery disease in a chinese han population: a case control study. Lipids in Health and Disease 2012 11, article 128 10.1186/1476-511X-11-128
13. Xiao Y. J., Zhang Y., Lv X. F., Relationship between lipid profiles and plasma total homocysteine, cysteine and the risk of coronary artery disease in coronary angiographic subjects. Lipids in Health and Disease 2011 10
14. Roger V. L., Go A. S., Lloyd-Jones D. M., Heart disease and stroke statistics-2011 update: a report from the american heart association. Circulation 123 e18 e209
15. Ritsch A., Scharnagl H., Eller P., Tancevski I., Duwensee K., Demetz E., Sandhofer A., Boehm B. O., Winkelmann B. R., Patsch J. R., März W., Cholesteryl ester transfer protein and mortality in patients undergoing coronary angiography: the ludwigshafen risk and cardiovascular health study. Circulation 2010 121 3 366 374 2-s2.0-76649140069 10.1161/CIRCULATIONAHA.109.875013
16. Zhang B., Wang P., Chen C.-G., He Q. Q., Zhuo S. Y., Chen Y. M., Su Y. X., Validation of an FFQ to estimate the intake of fatty acids using erythrocyte membrane fatty acids and multiple 3d dietary records. Public Health Nutrition 2010 13 10 1546 1552 2-s2.0-77957240147 10.1017/S1368980009992849
17. Kolonel L. N., Henderson B. E., Hankin J. H., Nomura A. M. Y., Wilkens L. R., Pike M. C., Stram D. O., Monroe K. R., Earle M. E., Nagamine F. S., A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. American Journal of Epidemiology 2000 151 4 346 357 2-s2.0-18844474648
18. Volpato S., Guralnik J. M., Ferrucci L., Balfour J., Chaves P., Fried L. P., Harris T. B., Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study. Circulation 2001 103 7 947 953 2-s2.0-0035916309
19. Tuomisto K., Jousilahti P., Sundvall J., Pajunen P., Salomaa V., C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study. Thrombosis and Haemostasis 2006 95 3 511 518 2-s2.0-33645538914 10.1160/TH05-08-0571
20. Arai Y., Takayama M., Gondo Y., Inagaki H., Yamamura K., Nakazawa S., Kojima T., Ebihara Y., Shimizu K., Masui Y., Kitagawa K., Takebayashi T., Hirose N., Adipose endocrine function, insulin-like growth factor-1 axis, and exceptional survival beyond 100 years of age. Journals of Gerontology A 2008 63 11 1209 1218 2-s2.0-46949091012
21. Rao M., Guo D., Perianayagam M. C., Tighiouart H., Jaber B. L., Pereira B. J. G., Balakrishnan V. S., Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients. American Journal of Kidney Diseases 2005 45 2 324 333 2-s2.0-15944420205 10.1053/j.ajkd.2004.09.018
22. Danesh J., Kaptoge S., Mann A. G., Sarwar N., Wood A., Angleman S. B., Wensley F., Higgins J. P. T., Lennon L., Eiriksdottir G., Rumley A., Whincup P. H., Lowe G. D. O., Gudnason V., Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Medicine 2008 5 4, article e78 2-s2.0-43249118045 10.1371/journal.pmed.0050078
23. Haugen E., Gan L.-M., Isic A., Skommevik T., Fu M., Increased interleukin-6 but not tumour necrosis factor-alpha predicts mortality in the population of elderly heart failure patients. Experimental and Clinical Cardiology 2008 13 1 19 24 2-s2.0-41149116161
24. Panichi V., Maggiore U., Taccola D., Migliori M., Rizza G. M., Consani C., Bertini A., Sposini S., Perez-Garcia R., Rindi P., Palla R., Tetta C., Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients. Nephrology Dialysis Transplantation 2004 19 5 1154 1160 2-s2.0-2442551737 10.1093/ndt/gfh052
25. Candore G., Balistreri C. R., Listì F., Grimaldi M. P., Vasto S., Colonna-Romano G., Franceschi C., Lio D., Caselli G., Caruso C., Immunogenetics, gender, and longevity. Annals of the New York Academy of Sciences 2006 1089 516 537 2-s2.0-33847791008 10.1196/annals.1386.051
26. Yudkin J. S., Kumari M., Humphries S. E., Mohamed-Ali V., Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000 148 2 209 214 2-s2.0-0033984744 10.1016/S0021-9150(99) 00463-3
27. Van Der Poll T., Levi M., Hack C. E., Ten Cate H., Van Deventer S. J. H., Eerenberg A. J. M., De Groot E. R., Jansen J., Gallati H., Buller H. R., Ten Cate J. W., Aarden L. A., Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. Journal of Experimental Medicine 1994 179 4 1253 1259 2-s2.0-0028323245
28. Hardardottir I., Grunfeld C., Feingold K. R., Effects of endotoxin and cytokines on lipid metabolism. Current Opinion in Lipidology 1994 5 3 207 215 2-s2.0-0028245748
29. Mastorakos G., Chrousos G. P., Weber J. S., Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. Journal of Clinical Endocrinology and Metabolism 1993 77 6 1690 1694 2-s2.0-0027131202 10.1210/jc.77.6.1690
30. Baune B. T., Rothermundt M., Ladwig K. H., Meisinger C., Berger K., Systemic inflammation (interleukin 6) predicts all-cause mortality in men: results from a 9-year follow-up of the MEMO study. Age 2011 33 2 209 217 2-s2.0-79959562094 10.1007/s11357-010-9165-5
31. Jaremo P., Nilsson O., Interleukin-6 forecasts long-term mortality after acute myocardial infarctions. Bologna, Italy, Medimond S R L, 2007
32. Fisman E. Z., Benderly M., Esper R. J., Behar S., Boyko V., Adler Y., Tanne D., Matas Z., Tenenbaum A., Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction. American Journal of Cardiology 2006 98 1 14 18 2-s2.0-33745145788 10.1016/j.amjcard.2006.01.045
33. Swerdlow D. I., Holmes M. V., Kuchenbaecker K. B., The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. The Lancet 2012 379 1214 1224
34. Sarwar N., Butterworth A. S., Freitag D. F., Collaboration IRGCERF: interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. The Lancet 2012 379 1205 1213
35. Alley D. E., Crimmins E., Bandeen-Roche K., Guralnik J., Ferrucci L., Three-year change in inflammatory markers in elderly people and mortality: the Invecchiare in Chianti study. Journal of the American Geriatrics Society 2007 55 11 1801 1807 2-s2.0-35748958058 10.1111/j.1532-5415.2007.01390.x